🇺🇸 FDA

Drug profile · INN

umeclidinium bromide

ANORO ELLIPTA (PREVIOUSLY ANORO)

FDA: approved EMA: approved R03AL03
US status
approved
Patents linked
0
News articles
0

Quick answer

umeclidinium bromide (ANORO ELLIPTA (PREVIOUSLY ANORO)) is an FDA-listed pharmaceutical active ingredient. Route of administration: inhalation. Current US regulatory status: approved.

Key facts

INN umeclidinium bromide
Brand ANORO ELLIPTA (PREVIOUSLY ANORO)
Route INHALATION
Formulation POWDER
ATC code R03AL03

Frequently asked questions

What is umeclidinium bromide?

umeclidinium bromide (ANORO ELLIPTA (PREVIOUSLY ANORO)) is an FDA-listed pharmaceutical active ingredient. Route of administration: inhalation. Current US regulatory status: approved.

What is the brand name for umeclidinium bromide?

ANORO ELLIPTA (PREVIOUSLY ANORO) is a marketed brand name for umeclidinium bromide. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of umeclidinium bromide?

umeclidinium bromide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.